Edgewise Therapeutics, Inc.

NASDAQ (USD): Edgewise Therapeutics, Inc. (EWTX)

Last Price

29.50

Today's Change

+10.43 (54.69%)

Day's Change

24.84 - 29.95

Trading Volume

11,808,291

Overview

Market Cap

2 Billion

Shares Outstanding

93 Million

Avg Volume

974,509

Avg Price (50 Days)

18.78

Avg Price (200 Days)

16.45

PE Ratio

-19.28

EPS

-1.53

Earnings Announcement

07-Nov-2024

Previous Close

19.07

Open

25.75

Day's Range

24.84 - 29.95

Year Range

5.12 - 29.95

Trading Volume

11,808,291

Price Change Highlight

1 Day Change

54.69%

5 Day Change

66.95%

1 Month Change

49.59%

3 Month Change

75.49%

6 Month Change

75.91%

Ytd Change

168.18%

1 Year Change

375.81%

3 Year Change

71.21%

5 Year Change

-1.67%

10 Year Change

-1.67%

Max Change

-1.67%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment